Microbiome Dynamics: A Paradigm Shift in Combatting Infectious Diseases
- PMID: 38392650
- PMCID: PMC10890469
- DOI: 10.3390/jpm14020217
Microbiome Dynamics: A Paradigm Shift in Combatting Infectious Diseases
Abstract
Infectious diseases have long posed a significant threat to global health and require constant innovation in treatment approaches. However, recent groundbreaking research has shed light on a previously overlooked player in the pathogenesis of disease-the human microbiome. This review article addresses the intricate relationship between the microbiome and infectious diseases and unravels its role as a crucial mediator of host-pathogen interactions. We explore the remarkable potential of harnessing this dynamic ecosystem to develop innovative treatment strategies that could revolutionize the management of infectious diseases. By exploring the latest advances and emerging trends, this review aims to provide a new perspective on combating infectious diseases by targeting the microbiome.
Keywords: host–pathogen interactions; human microbiome; infectious diseases; microbiome-targeted therapies; treatment approaches.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Unraveling the Microbiome-Human Body Axis: A Comprehensive Examination of Therapeutic Strategies, Interactions and Implications.Int J Mol Sci. 2024 May 20;25(10):5561. doi: 10.3390/ijms25105561. Int J Mol Sci. 2024. PMID: 38791599 Free PMC article. Review.
-
Shaping the future of gastrointestinal cancers through metabolic interactions with host gut microbiota.Heliyon. 2024 Jul 27;10(15):e35336. doi: 10.1016/j.heliyon.2024.e35336. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39170494 Free PMC article. Review.
-
NEAT1 in inflammatory infectious diseases: An integrated perspective on molecular modulation.Pathol Res Pract. 2024 Feb;254:154956. doi: 10.1016/j.prp.2023.154956. Epub 2023 Nov 20. Pathol Res Pract. 2024. PMID: 38218038 Review.
-
Exploring the Human Microbiome: The Potential Future Role of Next-Generation Sequencing in Disease Diagnosis and Treatment.Front Immunol. 2019 Jan 7;9:2868. doi: 10.3389/fimmu.2018.02868. eCollection 2018. Front Immunol. 2019. PMID: 30666248 Free PMC article. Review.
-
Regulation of Gut Microbiota by Herbal Medicines.Curr Drug Metab. 2024;25(2):110-127. doi: 10.2174/0113892002287336240328083220. Curr Drug Metab. 2024. PMID: 38571357 Review.
Cited by
-
Impact of doxycycline post-exposure prophylaxis for sexually transmitted infections on the gut microbiome and antimicrobial resistome.Nat Med. 2024 Oct 3. doi: 10.1038/s41591-024-03274-2. Online ahead of print. Nat Med. 2024. PMID: 39363100
-
Unraveling the Microbiome-Human Body Axis: A Comprehensive Examination of Therapeutic Strategies, Interactions and Implications.Int J Mol Sci. 2024 May 20;25(10):5561. doi: 10.3390/ijms25105561. Int J Mol Sci. 2024. PMID: 38791599 Free PMC article. Review.
-
Doxycycline post-exposure prophylaxis for sexually transmitted infections impacts the gut antimicrobial resistome.Res Sq [Preprint]. 2024 Apr 17:rs.3.rs-4243341. doi: 10.21203/rs.3.rs-4243341/v1. Res Sq. 2024. Update in: Nat Med. 2024 Oct 3. doi: 10.1038/s41591-024-03274-2. PMID: 38699315 Free PMC article. Updated. Preprint.
References
-
- Costantini C., Nunzi E., Spolzino A., Merli F., Facchini L., Spadea A., Melillo L., Codeluppi K., Marchesi F., Marchesini G., et al. A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche Determinants. Infect. Immun. 2022;90:e0004822. doi: 10.1128/iai.00048-22. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources